Apogee Therapeutics, Inc. Common Stock (APGE) — Strategic Asset Allocation Index
Apogee Therapeutics, Inc. Common Stock (APGE) has a Strategic Asset Allocation Index of 15.8% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $198.35 Million) total $198.35 Million, measured against net assets of $1.26 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See APGE net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Apogee Therapeutics, Inc. Common Stock Strategic Asset Allocation Index (2023–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the index stands at 15.8%, representing strategic assets of $198.35 Million against net assets of $1.26 Billion USD. For live market cap and overall valuation, see APGE market cap overview.
Annual Strategic Asset Allocation Index for Apogee Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Apogee Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Apogee Therapeutics, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 19.1% | $172.73 Million | $- | $172.73 Million | $903.88 Million | ▼ -10.2 pp |
| 2024 | 29.4% | $210.42 Million | $- | $210.42 Million | $716.79 Million | ▲ +29.4 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $379.91 Million | — |